Daito Pharmaceutical Co Ltd
TSE:4577

Watchlist Manager
Daito Pharmaceutical Co Ltd Logo
Daito Pharmaceutical Co Ltd
TSE:4577
Watchlist
Price: 2 124 JPY -1.12% Market Closed
Market Cap: 32.5B JPY
Have any thoughts about
Daito Pharmaceutical Co Ltd?
Write Note

Daito Pharmaceutical Co Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Daito Pharmaceutical Co Ltd
Operating Expenses Peer Comparison

Comparables:
4502
4568
4578
4519
4503

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Daito Pharmaceutical Co Ltd
TSE:4577
Operating Expenses
-ÂĄ6B
CAGR 3-Years
-9%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Takeda Pharmaceutical Co Ltd
TSE:4502
Operating Expenses
-ÂĄ2.5T
CAGR 3-Years
-15%
CAGR 5-Years
-12%
CAGR 10-Years
-9%
Daiichi Sankyo Co Ltd
TSE:4568
Operating Expenses
-ÂĄ1T
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-8%
Otsuka Holdings Co Ltd
TSE:4578
Operating Expenses
-ÂĄ1.2T
CAGR 3-Years
-15%
CAGR 5-Years
-8%
CAGR 10-Years
-3%
Chugai Pharmaceutical Co Ltd
TSE:4519
Operating Expenses
-ÂĄ265B
CAGR 3-Years
-5%
CAGR 5-Years
-5%
CAGR 10-Years
-5%
Astellas Pharma Inc
TSE:4503
Operating Expenses
-ÂĄ1.6T
CAGR 3-Years
-21%
CAGR 5-Years
-16%
CAGR 10-Years
-8%

See Also

What is Daito Pharmaceutical Co Ltd's Operating Expenses?
Operating Expenses
-6B JPY

Based on the financial report for Aug 31, 2024, Daito Pharmaceutical Co Ltd's Operating Expenses amounts to -6B JPY.

What is Daito Pharmaceutical Co Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-7%

Over the last year, the Operating Expenses growth was -14%. The average annual Operating Expenses growth rates for Daito Pharmaceutical Co Ltd have been -9% over the past three years , -8% over the past five years , and -7% over the past ten years .

Back to Top